Induction of hemodialysis therapy in a case with factor XIII deficiency.

Clin Exp Nephrol

Department of Nephrology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Published: October 2011

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10157-011-0473-6DOI Listing

Publication Analysis

Top Keywords

induction hemodialysis
4
hemodialysis therapy
4
therapy case
4
case factor
4
factor xiii
4
xiii deficiency
4
induction
1
therapy
1
case
1
factor
1

Similar Publications

Background: Granulocyte and monocyte adsorption apheresis (GMA) is a therapeutic option for remission induction in the active ulcerative colitis (UC) patients. Effects of high processed blood volume of GMA as remission induction therapy on the long-term prognosis of UC patients have remained unclear. For this study, we investigated the relation between re-exacerbation of UC and the processed blood volume of GMA performed as induction therapy.

View Article and Find Full Text PDF

After kidney transplantation, conversion to belatacept is a promising alternative in patients with poor graft function or intolerance to calcineurin inhibitors. The risk of acute rejection has not been well described under these conditions. Here we present a retrospective multicenter study investigating the occurrence of acute rejection after conversion in 901 patients (2011-2021).

View Article and Find Full Text PDF

Glomerular endothelial cell (GEnC) injury is a common feature across the wide spectrum of glomerular diseases. We recently reported that the endothelial-specific knockout of increases the susceptibility to GEnC injury and subsequent development of subacute thrombotic microangiopathy (TMA). However, the mechanism(s) mediating GEnCs response to injury in TMA are poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Granulomatosis with polyangiitis is a type of vasculitis affecting small to medium-sized blood vessels, with kidney involvement impacting prognosis.
  • Treatment for severe cases often involves a combination of corticosteroids and medications like rituximab or cyclophosphamide, but there's no clear consensus on the best regimen.
  • The case discussed highlights the effectiveness of using lower-dose cyclophosphamide alongside rituximab for patients with treatment-resistant forms of the disease and emphasizes better tolerance at lower doses.
View Article and Find Full Text PDF

Diffuse large B-cell lymphoma with rapid kidney enlargement after induction of hemodialysis in a patient with IgG4-related disease.

CEN Case Rep

December 2024

Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

A 76-year-old Japanese man was incidentally diagnosed with a pancreatic head tumor on computed tomography after surgery for colon cancer. He underwent pancreatoduodenectomy and was diagnosed with IgG4-related autoimmune pancreatitis. Concurrent chronic kidney disease gradually progressed and chronic hemodialysis was introduced 2 years later.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!